ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $343,000 | +36.1% | 18,132 | -15.4% | 0.00% | – |
Q2 2019 | $252,000 | +20.6% | 21,428 | +39.7% | 0.00% | – |
Q1 2019 | $209,000 | +23.7% | 15,339 | -7.3% | 0.00% | – |
Q4 2018 | $169,000 | -37.2% | 16,546 | +2.6% | 0.00% | – |
Q3 2018 | $269,000 | +5.5% | 16,123 | -0.0% | 0.00% | – |
Q2 2018 | $255,000 | +27.5% | 16,131 | +2.6% | 0.00% | – |
Q1 2018 | $200,000 | -52.6% | 15,717 | -57.4% | 0.00% | – |
Q4 2017 | $422,000 | +76.6% | 36,881 | +89.1% | 0.00% | – |
Q3 2017 | $239,000 | +408.5% | 19,505 | +370.8% | 0.00% | – |
Q2 2017 | $47,000 | -59.8% | 4,143 | -26.0% | 0.00% | – |
Q1 2017 | $117,000 | +2825.0% | 5,602 | +3047.2% | 0.00% | – |
Q4 2016 | $4,000 | -33.3% | 178 | 0.0% | 0.00% | – |
Q3 2016 | $6,000 | +50.0% | 178 | 0.0% | 0.00% | – |
Q2 2016 | $4,000 | -50.0% | 178 | -45.1% | 0.00% | – |
Q1 2016 | $8,000 | +14.3% | 324 | +54.3% | 0.00% | – |
Q4 2015 | $7,000 | 0.0% | 210 | 0.0% | 0.00% | – |
Q3 2015 | $7,000 | – | 210 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |